(2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide

C51H68N10O7S — CID 166115297

IUPAC(2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide
SMILESCCn1c2c3c4cc(ccc41)-c1csc(n1)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)N1CCN(C(=O)/C=C/CN(C)C)C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C3[C@H](OC)c1ncccc1-2
InChIInChI=1S/C51H68N10O7S/c1-11-59-38-19-18-32-25-34(38)41-42(46(67-10)43-33(45(41)59)15-12-20-52-43)51(5,6)29-68-49(65)35-16-13-22-61(55-35)48(64)36(26-39-53-37(32)28-69-39)54-47(63)44(30(2)3)57(9)50(66)60-24-23-58(27-31(60)4)40(62)17-14-21-56(7)8/h12,14-15,17-20,25,28,30-31,35-36,42,44,46,55H,11,13,16,21-24,26-27,29H2,1-10H3,(H,54,63)/b17-14+/t31-,35-,36-,42?,44-,46-/m0/s1
InChIKeyVSYUBNNMMQNEMB-YCWDOYJHSA-N
MW965.23 g/mol
LogP5.46
Rot. Bonds9

About (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide

(2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide (PubChem CID 166115297) has the molecular formula C51H68N10O7S and a molecular weight of 965.23 g/mol. Its IUPAC name is (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide.

Molecular Properties

Compound Name(2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide
PubChem CID166115297
Molecular FormulaC51H68N10O7S
Molecular Weight965.23 g/mol
Exact Mass964.50
IUPAC Name(2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide
SMILESCCn1c2c3c4cc(ccc41)-c1csc(n1)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)N1CCN(C(=O)/C=C/CN(C)C)C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C3[C@H](OC)c1ncccc1-2
InChIInChI=1S/C51H68N10O7S/c1-11-59-38-19-18-32-25-34(38)41-42(46(67-10)43-33(45(41)59)15-12-20-52-43)51(5,6)29-68-49(65)35-16-13-22-61(55-35)48(64)36(26-39-53-37(32)28-69-39)54-47(63)44(30(2)3)57(9)50(66)60-24-23-58(27-31(60)4)40(62)17-14-21-56(7)8/h12,14-15,17-20,25,28,30-31,35-36,42,44,46,55H,11,13,16,21-24,26-27,29H2,1-10H3,(H,54,63)/b17-14+/t31-,35-,36-,42?,44-,46-/m0/s1
InChIKeyVSYUBNNMMQNEMB-YCWDOYJHSA-N
XLogP5.46
TPSA174.78 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms69
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500965.23
LogP ≤ 55.46
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide?
The IUPAC name of (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide (CID 166115297) is (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide.
What is the SMILES notation for (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide?
The canonical SMILES for (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide is CCn1c2c3c4cc(ccc41)-c1csc(n1)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)N1CCN(C(=O)/C=C/CN(C)C)C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C3[C@H](OC)c1ncccc1-2.
What is the InChIKey of (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide?
The InChIKey is VSYUBNNMMQNEMB-YCWDOYJHSA-N. The full InChI is InChI=1S/C51H68N10O7S/c1-11-59-38-19-18-32-25-34(38)41-42(46(67-10)43-33(45(41)59)15-12-20-52-43)51(5,6)29-68-49(65)35-16-13-22-61(55-35)48(64)36(26-39-53-37(32)28-69-39)54-47(63)44(30(2)3)57(9)50(66)60-24-23-58(27-31(60)4)40(62)17-14-21-56(7)8/h12,14-15,17-20,25,28,30-31,35-36,42,44,46,55H,11,13,16,21-24,26-27,29H2,1-10H3,(H,54,63)/b17-14+/t31-,35-,36-,42?,44-,46-/m0/s1.
What are the key properties of (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide?
(2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide has a molecular weight of 965.23 g/mol, XLogP of 5.46, 9 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-4-[(E)-4-(dimethylamino)but-2-enoyl]-N-[(2S)-1-[[(10S,16S,22S)-33-ethyl-10-methoxy-12,12-dimethyl-15,21-dioxo-14-oxa-25-thia-8,20,33,34,35-pentazaheptacyclo[26.3.1.13,31.116,20.124,27.02,11.04,9]pentatriaconta-1(31),2,4(9),5,7,24(34),26,28(32),29-nonaen-22-yl]amino]-3-methyl-1-oxobutan-2-yl]-N,2-dimethylpiperazine-1-carboxamide is sourced from PubChem (CID 166115297), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).